Efficacy and Safety of Pembrolizumab in Patients Enrolled in KEYNOTE-030 in the United States: An Expanded Access ProgramTara C. Gangadhar, April K.S. Salama, Michael A. Postow et al.|Journal of Immunotherapy|2017Cited by 18